A61L 24/108
Specific proteins or polypeptides not covered by groups a61l24/102 - a61l24/106
Official title: {Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106}
A61L24/108 (Specific proteins or polypeptides not covered by groups a61l24/102 - a61l24/106) appears on 162 US grants and 248 published applications in this corpus.
Search patents in A61L- Granted patents
- 162
- Published applications
- 248
- Assignees
- 161
- Inventors
- 474
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 3 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 2 |
| 2002 | 4 | 7 |
| 2003 | 2 | 8 |
| 2004 | 2 | 7 |
| 2005 | 1 | 12 |
| 2006 | 3 | 10 |
| 2007 | 3 | 12 |
| 2008 | 4 | 7 |
| 2009 | 5 | 9 |
| 2010 | 9 | 11 |
| 2011 | 4 | 6 |
| 2012 | 7 | 9 |
| 2013 | 5 | 5 |
| 2014 | 5 | 6 |
| 2015 | 6 | 12 |
| 2016 | 6 | 19 |
| 2017 | 9 | 8 |
| 2018 | 7 | 14 |
| 2019 | 10 | 11 |
| 2020 | 8 | 12 |
| 2021 | 8 | 9 |
| 2022 | 6 | 17 |
| 2023 | 5 | 10 |
| 2024 | 10 | 7 |
| 2025 | 5 | 10 |
| 2026 | 7 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Embolization hydrogel having controllable degradation time, and preparation method therefor9 Jun 2026US 12,649,015 B2Nextbiomedical Co., Ltd.
- Mid-infrared laser-activated tissue sealing using biomaterials2 Jun 2026US 12,642,515 B2Arizona Board of Regents on behalf of Arizona State University
- Vascular embolic system19 May 2026US 12,629,446 B23-D Matrix, Ltd.
- Adhesion preventing material for ophthalmic applications, and method for producing same21 Apr 2026US 12,605,481 B2BMG Incorporated
- Methods and devices for changing the flow rates of pH modifying fluids for controlling cross-linking rates of reactive components of biocompatible sealing compositions17 Mar 2026US 12,576,183 B2Ethicon, Inc.
- Vascular embolic system16 Jul 2026US 2026/0199545 A13-D Matrix, Ltd.
- Embolics with immune-enhancing anti-carcinogenic properties25 Jun 2026US 2026/0174894 A1Bard Peripheral Vascular, Inc.
- Two-component in-situ adhesive based on supercharged protein, and preparation method and use thereof30 Apr 2026US 2026/0115351 A1Beijing Lanthanide Biotechnology Co., Ltd
- Self-assembling peptide compositions30 Apr 2026US 2026/0116919 A13-D Matrix, Ltd.
- Peptide-based non-crystalline materials and compositions and processes for obtaining same23 Apr 2026US 2026/0109870 A1Ramot at Tel-Aviv University Ltd.
Most cited
By later US patents
- Method and compositions for the treatment and repair of defects or lesions in cartilage470US 5,206,023 A1993
- Methods and compositions for the treatment and repair of defects or lesions in cartilage399US 5,368,858 A1994
- Methods of and apparatus for treating vascular defects297US 6,375,606 B1Stereotaxis, Inc. · 2002
- Compositions and therapeutic methods using morphogenic proteins and stimulatory factors265US 5,948,428 AStryker Corporation · 1999
- Methods of and compositions for treating vascular defects238US 6,364,823 B1Stereotaxis, Inc. · 2002